Journal profile · INFECTIOUS DISEASES

GERMS

ISSN 2248-2997 · European Academy of HIV/AIDS and Infectious Diseases

GERMS: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; median 36 days to acceptance (30 articles, last 24 months); 33 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time36 daysMedian, submission to acceptance · 30 articles, last 24 months · PubMed
APC—No source gives fee information
Acceptance—No reports yet
Articles per year332025 · OpenAlex count

Scope

Aims, scope and focus

GERMS is published by European Academy of HIV/AIDS and Infectious Diseases and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing and Antimicrobial Resistance in Staphylococcus, together about 22.7% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): INFECTIOUS DISEASES

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology11.4%
  2. Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.8%
  3. Antimicrobial Resistance in StaphylococcusMedicine5.6%
  4. Tuberculosis Research and EpidemiologyMedicine5%
  5. Antibiotic Use and ResistanceImmunology and Microbiology4.8%
  6. HIV-related health complications and treatmentsMedicine4.8%
  7. HIV/AIDS Research and InterventionsMedicine4.4%
  8. Bacterial biofilms and quorum sensingBiochemistry, Genetics and Molecular Biology4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorInfectious DiseasesZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorInfectious DiseasesZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
2.9LetPub ·
SJR 2026-06
0.43LetPub ·
SNIP 2026-06
0.62LetPub ·
h-index
31OpenAlex ·
i10-index
156OpenAlex ·
2-year mean citedness
2.1OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
36%LetPub ·

Volume

Articles per year
28LetPub ·

Articles by year OpenAlex count · 501 in total · the current year is incomplete

YearArticlesOpen accessCitations
202622223
2025332946
20243636142
20235151241
20226060477
202166661,004

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

36 daysMedian, submission to acceptance · P25–P75 21 days – 80 days

Acceptance to online
median 2 days (31 articles)
Submission to online
median 67 days
Sample
30 articles with submission and acceptance dates (33 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
European Academy of HIV/AIDS and Infectious Diseases
ISSN
2248-2997
Official links

FAQ

Frequently asked questions about GERMS

What CAS zone is GERMS in?

In the 2025 upgraded edition of the CAS Journal Ranking, GERMS is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at GERMS?

Based on the dates recorded on 30 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 36 days (interquartile range 21–80 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index GERMS?

According to LetPub and DOAJ records, GERMS is indexed in ESCI and Scopus.

Is GERMS open access, and what is the APC?

GERMS is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .